The Centers for Disease Control and Prevention recently reported that gabapentin was involved in one out of every 10 fatal overdose deaths in reporting states.
Similar to opioids, gabapentin can cause severe breathing difficulties, which are exacerbated when the drug is combined with other central nervous system depressants (opioids, antidepressants, antianxiety meds).
Illicit use of gabapentin appears to be on the rise. From JAMA:
Gabapentin can produce feelings of euphoria and intoxication and can potentiate opioids’ effects. Individuals who misused the drug reported multiple reasons in a 2019 study, including a desire to enhance the effects of opioids; to achieve a “high” when preferred substances were unavailable, such as when they were living in a treatment facility or were incarcerated; or to self-treat withdrawal or pain.
Gabapentin is a non-scheduled drug that became much more widely prescribed as opioid scripts declined. Back in 2018, one out of five chronic pain patients was prescribed gabapentin (or its cousin, pregabalin). There’s some evidence that misuse of gabapentin, which is almost always prescribed off-label, often occurs after the consumer had a prescription for the drug.
And, Parke-Davis, manufacturer of Neurontin, the brand name version of gabapentin, pleaded guilty to promoting off-label use and paid a $430 million fine.
So, what to do?
First, learn more. Start here: myMatrixx’ Shanea McKinney penned an excellent overview way back in 2019.
Then:
What does this mean for you?
This looks awfully familiar.
Joseph Paduda is co-owner of CompPharma, a consulting firm focused on improving pharmacy programs in workers’ compensation. This column is republished with his permission from his Managed Care Matters blog.
May 5-8, 2024
Amplify Your Impact There’s no limit to what you can achieve when you join the global risk managem …
May 13-15, 2024
Join us May 13–15, 2024, for NCCI's Annual Insights Symposium (AIS) 2024, the industry’s premier e …
May 13-14, 2024
The Board of Managers is excited to announce that the CSIA 2024 Annual Meeting and Educational Con …
No Comments
Log in to post a comment